(0.39%) 5 119.98 points
(0.31%) 38 360 points
(0.50%) 16 007 points
(-0.51%) $83.42
(2.39%) $1.969
(-0.13%) $2 344.20
(-0.17%) $27.49
(2.69%) $946.90
(0.04%) $0.935
(-0.03%) $11.02
(-0.24%) $0.798
(1.91%) $93.63
0.00% HKD 0.960
Live Chart Being Loaded With Signals
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 1.26M |
Średni wolumen | 11.66M |
Kapitalizacja rynkowa | 417.88M |
EPS | HKD0 ( 2024-03-28 ) |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -0.360 |
ATR14 | HKD0.00500 (0.52%) |
Wolumen Korelacja
Kintor Pharmaceutical Ltd Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kintor Pharmaceutical Ltd Korelacja - Waluta/Towar
Kintor Pharmaceutical Ltd Finanse
Annual | 2022 |
Przychody: | HKD0 |
Zysk brutto: | HKD0 (0.00 %) |
EPS: | HKD-2.53 |
FY | 2022 |
Przychody: | HKD0 |
Zysk brutto: | HKD0 (0.00 %) |
EPS: | HKD-2.53 |
FY | 2021 |
Przychody: | HKD34.23M |
Zysk brutto: | HKD34.23M (100.00 %) |
EPS: | HKD-2.72 |
FY | 2020 |
Przychody: | HKD0.00 |
Zysk brutto: | HKD0.00 (0.00 %) |
EPS: | HKD-1.640 |
Financial Reports:
No articles found.
Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline also comprise ALK-1 antibody for the treatment of metastatic hepatocellular carcinoma (HCC) and various solid tumours; GT20029, a topical AR-PROTAC compound for the treatment of AGA and acne vulgaris; and PD-L1/TGF-ß, a dual target antibody to treat non-small cell lung cancer, biliary tract cancer, triple negative breast cancer, and HPV-associated tumours. In addition, the company's products pipeline include Detorsertib for the treatment of metastatic solid tumours, such as breast cancer, prostate cancer, and HCC; and Hedgehog/SMO Inhibitor, an inhibitor of the hedgehog signal transduction pathway to treat blood cancer and basal-cell carcinoma. Kintor Pharmaceutical Limited was founded in 2009 and is headquartered in Suzhou, the People's Republic of China.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej